A retrospective study to determine real-world effectiveness and use of Vedolizumab in ulcerative colitis or crohns disease patients in Virgen de las Nieves University Hospital
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Pharmacokinetics; Therapeutic Use
- 06 Dec 2021 New trial record